NCT04706533View on ClinicalTrials.gov

Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19

CompletedOBSERVATIONAL
Enrollment

3,402

Participants

Timeline

Start Date

March 23, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
Covid19Kidney DiseasesInflammationSARS-CoV Infection
Interventions
DIAGNOSTIC_TEST

Biomarkers of inflammation

Biomarkers were measured on blood samples collected within 48 hours of admission

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT04706533 - Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19 | Biotech Hunter | Biotech Hunter